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Abstract We present the results of a study of human prostate
specimens evaluated by high resolution magic angle spinning 1H
nuclear magnetic resonance (NMR) spectroscopy at 400 MHz
(9.4 T) and by quantitative histopathology. We demonstrate that
NMR and pathology data can be obtained from the same intact
specimens, and report for the first time a linear correlation
between the NMR measured concentration of spermine, a
proposed endogenous inhibitor to prostate cancer growth, and
the volume percentage of normal prostatic epithelial cells as
quantified by histopathology. Our results show that NMR may
serve as a critical tool for the investigation of the inhibitory
mechanism of spermine in human subjects. ß 2001 Published
by Elsevier Science B.V. on behalf of the Federation of Euro-
pean Biochemical Societies.
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1. Introduction
The controversy surrounding prostate cancer has presented
great challenges to medical and scienti¢c communities and has
generated enormous concerns in the public. The dilemma is
highlighted by the increasingly high incidence of diagnoses
resulting from improved detecting technologies, the relatively
moderate mortality rate of many prostate cancer cases, and
the high probability of complications accompanying local
treatments. Clinical data indicate that compared with other
malignancies, primary prostate cancers grow at a relatively
slow rate, but the growth rates of prostate cancer at distant
metastatic sites are similar to other more aggressive malignan-
cies.
The seemingly indolent characteristic of organ-con¢ned
prostate cancer has been a focus of studies seeking to under-
stand the inhibitory mechanism and to exploit its potential
utility in therapy regimens [1^3]. As one such inhibitor, sper-
mine has shown down-regulatory e¡ects on the growth of
prostate cancer cells when analyzed in vitro, and has thus
generated a number of intriguing questions with respect to
its function in human prostate [1]. Direct answers to these
questions can only be obtained from studies of human sub-
jects ; however, the use of human specimens presents a number
of vexing challenges not faced by studies of cell lines.
Chief among these challenges are the so called ‘sampling
errors’ raised from heterogeneity of cancer tissues. By any
rigorous standard, very little may con¢dently be assumed re-
garding the biology and biochemistry of a particular region in
an individual tumor, unless specimens from that tumor region
are evaluated directly. This requirement, however, often poses
a serious incompatibility between the procedures of histopa-
thology and biochemistry. Thus, any study that investigates
correlations between biochemistry and pathology, the ‘gold
standard’ for cancer diagnosis, must make use of bio-analyt-
ical procedures that are non-destructive and transparent to
histopathological evaluation.
Nuclear magnetic resonance (NMR) spectroscopy, a non-
invasive technique, has been considered as a promising candi-
date to accomplish this task [4]. Intact specimens and extract
solutions of tissue from prostate cancer patients have been
studied by using conventional solution proton NMR methods
[5^8]. However, because solution methods are not optimized
for intact tissue analysis, and because the destructive proce-
dures of the tissue extraction prevent further histopathological
evaluation, correlations between NMR results and pathology
have proven to be di⁄cult to reach.
Here, we address this obstacle by using high resolution
magic angle spinning (HRMAS), a NMR methodology devel-
oped for the analysis of intact tissue specimens [9,10].
HRMAS signi¢cantly di¡ers from solution methods used in
previous studies [5,8]. Speci¢cally, HRMAS allows us to ob-
tain high resolution spectra from intact tissue, comparable to
those achievable with aqueous extract solutions, but preserves
the tissue structures necessary for subsequent histopathologi-
cal examinations.
Our results show, for the ¢rst time, that spermine in human
prostate quanti¢ed by NMR correlates with the volume per-
centage (vol%) of normal prostatic epithelial cells measured
by histopathology. The connection between spermine and
prostate pathology, as the ¢rst step towards the investigation
of the mechanism of spermine on prostate cancer growth,
suggests that the hypothesized inhibitory function of spermine
can now be clinically examined through NMR studies of hu-
man subjects.
0014-5793 / 01 / $20.00 ß 2001 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 1 ) 0 2 3 2 9 - 8
*Corresponding author. Pathology Research CNY-7, 149 13th street,
Charlestown, MA 02129, USA. Fax: (1)-617-726 5684.
E-mail: cheng@nmr.mgh.harvard.edu
Abbreviations: NMR, nuclear magnetic resonance; HRMAS, high
resolution magic angle spinning
FEBS 24762 2-4-01
FEBS 24762FEBS Letters 494 (2001) 112^116
2. Materials and methods
Use of human materials in the study was reviewed and approved by
the IRB at the Massachusetts General Hospital, Boston, MA, USA.
2.1. Tissue specimens
Human prostate specimens used for this study (n = 16) were ob-
tained from the tissue repository at the Cancer Center of the Massa-
chusetts General Hospital. Patients’ medical records showed that
among these cases, nine were adenocarcinomas having a Gleason
score of 6/10 (grades: 3/5+3/5, age 60.5 þ 1.7), six had a score of
7/10 (grades: 3/5+4/5, age 63.8 þ 2.1), and one was a surgical specimen
collected as a normal control for research. No therapy was adminis-
tered to the cancer patients prior to the surgery.
Tissue specimens were snap-frozen in liquid nitrogen and main-
tained at 380‡C until the time of spectroscopic analysis. Approxi-
mately 50^100 mg of tissue from each case was obtained. Each speci-
men was divided into two halves. One half was used for the NMR
analysis; the other half was saved for histopathological evaluation in
order to determine the histopathological integrity of the specimen
after NMR analysis. Before NMR analysis, frozen specimens were
cut and weighed (between 16.3 and 47.0 mg, mean 35.7 þ 2.2 mg),
positioned within a HRMAS rotor, and transferred into the NMR
probe-head pre-cooled to 3‡C. The NMR study, performed at 3‡C,
began immediately at tissue thawing. Directly after the NMR study,
the specimens were ¢xed for subsequent quantitative histopathology
examinations.
2.2. Quantitative histopathology
Tissue samples were ¢xed in 10% formalin, embedded in para⁄n,
cut into 5-micron sections, and stained with hematoxylin and eosin.
Specimens that were obtained from 15 cases of clinically proven pros-
tate cancer and that were measured with NMR were subjected to
serial sections of one slide per 50^60 microns, while only one random
slide was sectioned from the other half of a specimen that was not
studied by NMR. Serial sections yielded 10^24 histopathological
slides depending on the size and orientation of the individual sample.
Cross-sections of each sample were quanti¢ed by a microscopic
image analyzer Image-Pro PLUS1 (Media Cybernetics0, Silver
Spring, MD, USA). The percentages of areas representing cancer
cells, normal epithelial cells and stroma structures in each cross-sec-
tion were estimated visually to the nearest 5% by a single pathologist
who did not have knowledge of the spectroscopic results. The re-
ported vol% of each pathological presentation was calculated based
on the size of the cross-section and the corresponding area percen-
tages of each pathological feature. All slides were evaluated twice in a
random order by the same pathologist over a time interval of 10
months. The data from these two evaluations were averaged to cal-
culate vol%.
2.3. Proton NMR spectroscopy
The procedures used for NMR measurements and data processing
have previously been described [10]. In brief, the HRMAS experi-
ments were performed at 3‡C on an MSL400 NMR spectrometer
(proton frequency at 400.13 MHz) by using a BD-MAS probe; tem-
perature was controlled by a VT-1000 unit, in combination with a
MAS-DB pneumatic unit (Bruker Instruments, Inc., Billerica, MA,
USA). Sample spinning rates were in the range of 2.34^2.49 kHz
( þ 2 Hz). A rotor-synchronized Carr^Purcell^Meibom^Gill (CPMG)
pulse sequence (90-(d-180-d)n acquisition) was used to function as a T2
¢lter to suppress broad signals from macromolecules. The inter-pulse
delay (d= 2Z/gr) was synchronized with the rotor rotation (d indicates
the sample spinning rate in time units and gr/2Z represents the spin-
ning rate in kHz). The value of n for each sample was adjusted to
create a T2 ¢lter of 2nd= 50 ms. The 90‡ pulse length, which varied
from 8.6 to 10.9 Ws, was also adjusted individually for each sample.
The number of transients was 256, with an acquisition time of 10 ms.
A repetition time of 5.0 s, a spectral width of 8 kHz (20 ppm), and 16
time domain data points were employed. Spectra were collected both
with and without suppression of resonance signals from tissue water.
Water presaturation was achieved with a DANTE type pulse sequence
(a^d)n, where a= 2.5 Ws and n = 2000, placed prior to the CPMG pulse
sequence.
Spectroscopic data were processed with NMR1 software (New
Method Research, Inc., Syracuse, NY, USA). All free induction de-
cays were subjected to 1 Hz apodization before Fourier transforma-
tion and phase adjustment. Regional integrals of the cellular metab-
olites from 0.5 to 4.5 ppm in spectra both with and without water
presaturation were measured and used in the calculation of metabolite
concentrations. Reported resonance integrals of spermine at 3.09^1.13
ppm and citrate at 2.52^2.73 ppm are integrals of curve-¢ttings ac-
cording to Lorentzian line-shapes. The broad resonance(s) of sper-
mine were ¢tted by two^four Lorentzians that could best represent
the total area of the region, while four Lorentzians were used to ¢t
each of the citrate signals at 2.52, 2.56, 2.69, and 2.73 ppm.
Tissue water signals, measured from spectra without water presatu-
ration, were used as an internal standard for the estimation of the
concentration of cellular metabolites. The concentrations of a metab-
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where IH2O and IMet=H2O represent the intensities of tissue water and
the metabolite region (0.5^4.5 ppm) from spectra without water pre-
saturation, respectively; IM and IMet represent the intensities of the
metabolite of interest and the same metabolite region measured from
spectra with water presaturation; and m is the number of protons of
the metabolite that give rise to the resonance of IM. The estimation is
also based on the approximation that tissue contains 80% (weight) of
water, i.e. 44 mmol/g. The regional metabolic intensities integrated
from 0.5 to 4.5 ppm for both spectra were used to convert intensities
of water and the metabolite of interest integrated separately from
these two spectra measured with di¡erent experimental parameters
into a comparable common scale.
2.4. Statistical analysis
Upon the completion of both NMR and histopathology measure-
ments, the two sets of data were combined and analyzed with the
statistical program JMP (SAS Institute, Cary, NC, USA). Correla-
tions between metabolite concentrations and the vol% of normal pro-
static epithelial cells were evaluated by bivariate linear least squares
¢ts.
Fig. 1. 400 MHz HRMAS proton MR spectra (water-suppressed,
T2-¢ltered) obtained from intact but previously frozen tissue:
(A) normal human prostate; (B) tumor-bearing prostate.
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3. Results and discussion
3.1. High resolution proton NMR spectra of intact prostate
tissue specimens
Fig. 1 shows examples of HRMAS 1H NMR spectra
(water-suppressed, T2-¢ltered) obtained with the same mea-
surement protocol from intact human tissue specimens of nor-
mal prostate (A) and prostate cancer (B). Fig. 1A presents
cellular metabolites observed in a specimen containing 45
vol% of epithelial cells and 55 vol% stroma structure, as de-
termined by histopathological quanti¢cation of the specimen
after its NMR measurement. Fig. 1B pro¢les a specimen con-
taining 23 vol% malignancy, 17 vol% epithelial cells and 60
vol% stroma. Labels in the ¢gure indicate selected resonances.
Major di¡erences between Fig. 1A and Fig. 1B are in the
regions labeled as spermine (Spm) and citrate (Cit). Spermine
has the symmetrical structure NH2-(CH2)3-NH-(CH2)4-NH-
(CH2)3-NH2 with ¢ve types of methylene groups giving rise
to complex multiplet signals at 3.09^3.13 ppm (-CH2-N, 12H),
2.09^2.10 ppm (N-CH2-CH2-CH2-N, 4H) and 1.78 ppm (N-
CH2-CH2-CH2-CH2-N, 4H), whereby the latter two signals
overlap with signals from amino acids. For this reason, only
the signals for methylenes next to amino groups could be used
in the analysis. These resonance regions of spermine are la-
beled with horizontal bars beneath Fig. 1A. At high magnetic
¢eld strength, citrate exhibits a well-resolved four-line pseudo-
quartet pattern (AB spin system) for the three chemically
equivalent methylene groups (6H). Normal tissue (Fig. 1A)
shows an abundance of these two metabolites, while the can-
cerous specimen (Fig. 1B) exhibits severe depletion in both
metabolites. The signal assignments are based on both the
literature [5^8] and our own measurements of authentic com-
pounds of spermine, spermidine, and putrescine using the
same experimental conditions as those used for tissue analysis
(data not shown). Although other polyamines (putrescine and
spermidine) would also have resonances in the 3.09^3.13 ppm
region, our results con¢rmed that spermine is the predomi-
nant polyamine in prostate as previously reported [11^13].
3.2. Histopathology evaluation
Histopathological evaluation was then conducted on the
airs of adjacent specimens taken from each case. Fig. 2 com-
pares such a pair of specimens from a tumor-bearing prostate
(with examples of cancer cells indicated by arrows). We ob-
served a slightly compromised histopathological quality for
specimens that had gone through HRMAS analysis when
compared with their paired counterpart, especially when cel-
lular details were examined at a high power of magni¢cation.
Nevertheless, the overall histopathological integrity of these
specimens was su⁄ciently preserved to permit the quanti¢ca-
tion of adenocarcinoma cells, normal epithelial cells, and stro-
ma structure in the specimen. Notably, among 15 clinical
cases of prostate adenocarcinomas (Gleason scores: 6/10
and 7/10), cancer cells were only detected histopathologically
in three cases (20%) of the surgical specimens available for
this study. In other words, had we not been able to perform
Fig. 2. Examples of histopathological images obtained from a pair of adjacent prostate tissue specimens taken from the same tumor-bearing
prostate. A,B: Tissue not subjected to HRMAS NMR (50U, 100U magni¢cation); C,D: adjacent tissue after HRMAS NMR analysis (50U,
100U).
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histopathology after NMR evaluation, we would have had no
means by which to recognize that 80% of the samples that
were studied with NMR contained no cancer cells.
3.3. Quantitative correlations between spectroscopy and
histopathology
Fig. 3 presents a linear regression analysis for the tissue
concentration of (Fig. 3, top) citrate and (Fig. 3, bottom)
spermine as a function of the vol% of normal epithelial cells,
as determined for each specimen. These statistically signi¢cant
correlations for citrate (r2 = 0.582, P6 0.001) and spermine
(r2 = 0.365, P6 0.018) suggest that the two metabolites likely
are either produced by or reside in the normal epithelial cells
of the prostate.
We notice the proposed biological importance of spermine
in relation to the growth of human prostate cancer, and rec-
ognize the potential interests that may be generated by this
study. In order for us to be entirely con¢dent in our interpre-
tation of spermine (Fig. 3, bottom), we compared spermine
with citrate, as determined by the same protocol (Fig. 3, top).
Compared with spermine, citrate has been widely studied as a
prostate metabolite by both in vivo and ex vivo NMR
[8,14,15]. Citrate, a secretory product under androgenic con-
trol, presents in high concentrations in the prostate. Since its
well-resolved typical AB spin pseudo-quartet signal pattern
[13] appears in a spectral region of 2.52^2.73 ppm that is
relatively free of resonances from other metabolites, both in
vivo and previously published ex vivo studies had little di⁄-
culty in detecting citrate. A reduction in citrate has consis-
tently been associated with prostate cancers measured in clinic
in vivo NMR spectroscopy [14,15]. Our results indicate the
58% of the variance in tissue citrate can be assigned to the
vol% of normal prostatic epithelial cells. This correlation,
which is demonstrated here for the ¢rst time by combined
histological and spectroscopic analysis of individual tissue
samples, provides an explanation for the well-established ob-
servation of reduction of citrate in prostate cancer [16].
Spermine in intact specimens has been more di⁄cult to
measure than citrate because, with conventional proton
NMR methods for solution, sample heterogeneity frequently
results in linebroadening. As a result of this, resonances at 3.1
ppm cannot be resolved from neighboring signals, including
those from creatine (3.03 ppm) and choline compounds (3.20^
3.30 ppm). However, HRMAS allows us to remove the resid-
ual solid-like e¡ects, such as magnetic susceptibility, to quan-
tify spermine in intact specimens and to relate concentration
to the population of prostate epithelial cells.
It is important to note that our measurements of intact
prostate tissue also resulted in a strong linear correlation be-
tween spermine and citrate (r2 = 0.75, P6 0.0001, ¢gures not
shown), in close agreement with the observation made by
Lynch and Nicholson with respect to human prostatic £uid
[13]. Although further molecular studies are needed to con¢rm
speculation about the existence of a molecular complex be-
tween the oppositely polared spermine and citrate, we never-
theless consider such a postulation to be a reasonable hypoth-
esis that may explain the apparent ionic neutrality of the
system and the reasonable chemical shift values of these me-
tabolites [13].
Finally, we wish to note that the newly established relation-
ships between spermine levels and normal prostatic epithelial
cells may allow us to carry out further investigations on hu-
man subjects, and to explore possible relationships between
the mechanism of spermine in prostatic epithelial cells and the
aggression of prostate cancer as observed and documented in
the clinic.
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